Allan-Herndon-Dudley-Syndrome: Considerations about the Brain Phenotype with Implications for Treatment Strategies

Krude, Heiko; Biebermann, Heike; Schuelke, Markus; Mueller, Timo D.; Tschoep, Matthias

dc.contributor.author	Müller, Timo Dirk
dc.date.accessioned	2020-08-31T13:28:40Z
dc.date.available	2020-08-31T13:28:40Z
dc.date.issued	2020
dc.identifier.issn	1439-3646
dc.identifier.uri	http://hdl.handle.net/10900/105984
dc.language.iso	en	de_DE
dc.publisher	Johann Ambrosius Barth Verlag Medizinverlage Heidelberg Gmbh	de_DE
dc.relation.uri	http://dx.doi.org/10.1055/a-1108-1456	de_DE
dc.subject.ddc	610	de_DE
dc.title	Allan-Herndon-Dudley-Syndrome: Considerations about the Brain Phenotype with Implications for Treatment Strategies	de_DE
dc.type	Article	de_DE
utue.quellen.id	20200715072417_00261
utue.publikation.seiten	414-422	de_DE
utue.personen.roh	Krude, Heiko
utue.personen.roh	Biebermann, Heike
utue.personen.roh	Schuelke, Markus
utue.personen.roh	Mueller, Timo D.
utue.personen.roh	Tschoep, Matthias
dcterms.isPartOf.ZSTitelID	Experimental and Clinical Endocrinology & Diabetes	de_DE
dcterms.isPartOf.ZS-Issue	6/7/2020	de_DE
dcterms.isPartOf.ZS-Volume	128	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE